| Short Description : | Recombinant-Human VAMP-2-His-Tag protein was developed from e.coli and has a target region of His-Tag. For use in research applications. |
| Applications: | SDS-PAGE |
| Host: | E.coli |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Concentration: | 1 mg/mL |
| Formulation: | Liquid in phosphate-buffered saline (pH 7.4) 1mM EDTA |
| Storage Instruction: | For short term storage, keep at +2C to +8C for up to 1 week. For long term storage, aliquot and store at-20C, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: | VAMP2 |
| Gene ID: | 6844 |
| Uniprot ID: | VAMP2_HUMAN |
| Accession Number: | NP_055047.2 |
| Immunogen: | Human |
| Immunogen Region: | 1-89aa |
| Immunogen Sequence: |
| Tissue Specificity | Nervous system and skeletal muscle. |
| Post Translational Modifications | Phosphorylated by PRKCZ in vitro and this phosphorylation is increased in the presence of WDFY2. (Microbial infection) Targeted and hydrolyzed by C.botulinum neurotoxin type B (BoNT/B, botB) which hydrolyzes the 76-Gln-|-Phe-77 bond and probably inhibits neurotransmitter release. (Microbial infection) Targeted and hydrolyzed by C.botulinum neurotoxin type D (BoNT/D, botD) which probably hydrolyzes the 59-Lys-|-Leu-60 bond and inhibits neurotransmitter release. Note that humans are not known to be infected by C.botulinum type D. (Microbial infection) Targeted and hydrolyzed by C.botulinum neurotoxin type F (BoNT/F, botF) which hydrolyzes the 58-Gln-|-Lys-59 bond and probably inhibits neurotransmitter release. (Microbial infection) Targeted and hydrolyzed by C.tetani tetanus toxin (tetX) which hydrolyzes the 76-Gln-|-Phe-77 bond and probably inhibits neurotransmitter release. |
| Function | Involved in the targeting and/or fusion of transport vesicles to their target membrane. Major SNARE protein of synaptic vesicles which mediates fusion of synaptic vesicles to release neurotransmitters. Essential for fast vesicular exocytosis and activity-dependent neurotransmitter release as well as fast endocytosis that mediates rapid reuse of synaptic vesicles. Modulates the gating characteristics of the delayed rectifier voltage-dependent potassium channel KCNB1. |
| Protein Name | Vesicle-Associated Membrane Protein 2Vamp-2Synaptobrevin-2 |
| Database Links | Reactome: R-HSA-1445148Reactome: R-HSA-181429Reactome: R-HSA-181430Reactome: R-HSA-199992Reactome: R-HSA-210500Reactome: R-HSA-212676Reactome: R-HSA-264642Reactome: R-HSA-264876Reactome: R-HSA-422356Reactome: R-HSA-432720Reactome: R-HSA-432722Reactome: R-HSA-449836Reactome: R-HSA-5250955Reactome: R-HSA-5250958Reactome: R-HSA-5250981Reactome: R-HSA-5250982Reactome: R-HSA-5250989Reactome: R-HSA-8856825Reactome: R-HSA-8856828Reactome: R-HSA-888590Reactome: R-HSA-9609523Reactome: R-HSA-9662360 |
| Cellular Localisation | Cytoplasmic VesicleSecretory VesicleSynaptic Vesicle MembraneSingle-Pass Type Iv Membrane ProteinCell MembraneColocalizes With Prkcz And Wdfy2 In Intracellular Vesicles |
| Alternative Protein Names | Vesicle-Associated Membrane Protein 2 proteinVamp-2 proteinSynaptobrevin-2 proteinVAMP2 proteinSYB2 protein |
Information sourced from Uniprot.org
